Sponsored By

WuXi Advanced Therapies Virology Operations: Cell & Gene Therapy Vector Regulatory Testing

BPI Contributor

March 18, 2022

20 Min View
WuXi Advanced Therapies Virology Operations: Cell & Gene Therapy Vector Regulatory Testing

Date: Mar 18, 2022

Duration: 20 Min

This webcast features: Andreas Solomos, PhD, Director, Virology Operations, WuXi Advanced Therapies.

Cell and gene therapy regulatory testing is a constantly evolving discipline as the field matures and data becomes more refined. Virology Operations at WuXi Advanced Therapies is able to provide testing for a variety of products ranging from small non-enveloped AAV vectors to large enveloped lentiviral vectors.

Our testing is performed as quickly as testing parameters permit without sacrificing the quality and integrity of results. Our panel of testing satisfies all ICH parameters delivering results on the quantity, stability, potency, identity, appearance, purity and safety of viral vector products.

We are evolving with the field to optimize our assays such as replication competence testing and infectious titer assays for scalability; we accommodate needs as products progress from early R&D and IND phase through clinical trials with the goal of sustaining the testing requirements and supporting through commercial release.

Just fill out the form below to watch the recorded webcast now.